apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Verquvo 2.5 mg Tablet 14's

Verquvo 2.5 mg Tablet 14's, Pack of 14 TabletS
Verquvo 2.5 mg Tablet 14's, Pack of 14 TabletS
Offers on medicine orders
All offers
axis icici
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

VERICIGUAT-2.5MG

Manufacturer/Marketer :

Bayer Zydus Pharma Pvt Ltd

Consume Type :

ORAL

Return Policy :

Not Returnable

Expires on or after :

About Verquvo 2.5 mg Tablet

Verquvo 2.5 mg Tablet belongs to the class of medications called soluble guanylate cyclase (sGC) stimulators. It is used to reduce the risk of death and the need for hospitalization in adults with heart failure. Heart failure is a condition in which the heart is unable to pump blood as effectively as it should.

Verquvo 2.5 mg Tablet contains Vericiguat, which works by relaxing the blood vessels in the lungs to allow blood to flow easily.

Use Verquvo 2.5 mg Tablet exactly as prescribed by the healthcare professional. Sometimes, Verquvo 2.5 mg Tablet may cause hypotension, anaemia, dizziness and light-headedness. Most of these side effects are temporary, do not require medical attention, and gradually resolve over time. However, if the side effects persist or worsen, contact your doctor.

Before taking Verquvo 2.5 mg Tablet , inform your doctor about all your allergic or hypersensitivity reactions to medicines or food. Verquvo 2.5 mg Tablet can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant while undergoing therapy and for one month after the treatment. Using effective contraceptive methods is recommended while on therapy with Verquvo 2.5 mg Tablet . Contact your doctor immediately if you or your partner becomes pregnant while undergoing therapy. Breastfeeding is usually not advised during this treatment. Safety and effectiveness in children have not been established.

Uses of Verquvo 2.5 mg Tablet

Verquvo 2.5 mg Tablet is used in the management of systolic heart failure to reduce mortality and hospitalizations. The detailed uses of Verquvo 2.5 mg Tablet are as follows:<br/>• Chronic heart failure with reduced ejection fraction (HFrEF): Verquvo 2.5 mg Tablet is used in adults with symptomatic chronic heart failure who have a left ventricular ejection fraction (LVEF) less than 45%. It helps the heart pump blood more efficiently by stimulating soluble guanylate cyclase (sGC), an enzyme involved in cardiovascular regulation.<br/>• Post-hospitalization heart failure management: Verquvo 2.5 mg Tablet is prescribed to reduce the risk of cardiovascular death and heart failure-related hospitalizations in patients who have recently been hospitalized for heart failure or required outpatient intravenous (IV) diuretics.<br/>• Improved blood circulation: Verquvo 2.5 mg Tablet works by relaxing blood vessels and improving blood flow, which helps reduce the workload on the heart and alleviates symptoms like breathlessness, fatigue, and swelling.<br/>

Directions for Use

• Take Verquvo 2.5 mg Tablet with food or as advised by your doctor.• It is recommended to take Verquvo 2.5 mg Tablet once daily; however, follow your doctor's advice regarding the dosage and duration.• Swallow the tablet as a whole with water. Tablets may be crushed and mixed with water for patients who have difficulty swallowing.• Do not chew Verquvo 2.5 mg Tablet .

Medicinal Benefits

Verquvo 2.5 mg Tablet contains Vericiguat, a soluble guanylate cyclase (sGC) stimulator. It is primarily used in adults who have symptoms of chronic (long-term) heart failure, have recently been hospitalized or require intravenous (IV) medications, and have an ejection fraction (amount of blood pumped with each heartbeat of less than 45 per cent) to reduce the risk of death and the need to be hospitalized. Vericiguat works by relaxing the blood vessels in the lungs to allow blood to flow easily.

How Verquvo 2.5 mg Tablet Works

Verquvo 2.5 mg Tablet contains Vericiguat, which works by relaxing the blood vessels in the lungs to allow blood to flow easily.

Storage

Store in a cool and dry place away from sunlight

What if I have taken an overdose of Verquvo 2.5 mg Tablet

Do not take more than prescribed dose. Using more medication will not improve your symptoms; rather they may cause poisoning or serious side-effects. If you suspect that you may have overdosed of Verquvo 2.5 mg Tablet , please go to the emergency department of the closest hospital or nursing home.

Drug Warnings

Before taking Verquvo 2.5 mg Tablet , let your doctor know about all your allergic or hypersensitivity reactions to medicines or food. Do not use Verquvo 2.5 mg Tablet and any medication for erectile dysfunction (male impotence) simultaneously. Please check with your doctor before using Verquvo 2.5 mg Tablet if you have/had anaemia, low blood pressure, or any severe medical illness. Before starting Verquvo 2.5 mg Tablet , inform your doctor about your medical history and ongoing therapies to rule out potential adverse effects or interactions.

Diet & Lifestyle Advise

  • Follow a cholesterol-lowering diet.
  • Consume low salt and a low-fat diet.
  • Exercise regularly. It helps in maintaining proper weight and lowers cholesterol.
  • Limit salt and sugar intake.
  • Avoid smoking and alcohol consumption.
  • Choose healthy fats and cut down on trans fats.
  • Include omega-3 fatty acids, fibre-rich food, fruits, and vegetables.
  • Get active by doing physical activities such as swimming, brisk walking, or jogging. Take the stairs instead of elevators/lifts.

Habit Forming

No

Therapeutic Class

MISCELLANEOUS

Verquvo 2.5 mg Tablet Substitute

Substitutes safety advice

Product Substitutes

bannner image

Alcohol

Caution

Intake of alcohol should be avoided with Verquvo 2.5 mg Tablet .

bannner image

Pregnancy

Unsafe

Verquvo 2.5 mg Tablet should not be used during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while taking Verquvo 2.5 mg Tablet .

bannner image

Breast Feeding

Unsafe

You should not breastfeed while taking this medication.

bannner image

Driving

Caution

Verquvo 2.5 mg Tablet may cause dizziness. So, driving vehicles and operating machinery which requires concentration should be avoided.

bannner image

Liver

Caution

Caution is advised. Verquvo 2.5 mg Tablet has not been studied in patients with severe hepatic impairment. Inform your doctor before using Verquvo 2.5 mg Tablet if you have liver problems or a history of liver conditions. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Kidney

Caution

Caution is advised. Inform your doctor before using Verquvo 2.5 mg Tablet if you have kidney problems or a history of kidney conditions. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Children

Unsafe

The safety and effectiveness of Verquvo 2.5 mg Tablet in children have not been established.

Have a query?

FAQs

Verquvo 2.5 mg Tablet is used to reduce the risk of death and the need for hospitalization in adults with heart failure.

Verquvo 2.5 mg Tablet contains Vericiguat, which works by relaxing the blood vessels and allowing blood to flow easily. As a result, the heart can pump more efficiently and does not have to work as hard. As a result, it helps to lower the risk of death and hospitalization in people with heart failure.

No, you should not combine Verquvo 2.5 mg Tablet with an erectile dysfunction medicine such as sildenafil or tadalafil since it may interfere with the blood pressure-lowering action of Verquvo 2.5 mg Tablet .

Yes, dizziness or light-headedness is the most common side effect encountered while using Verquvo 2.5 mg Tablet . Please take sufficient rest. If the problem persists, consult your doctor.

Verquvo 2.5 mg Tablet may not be recommended for patients with hypotension (low blood pressure); inform your doctor before using Verquvo 2.5 mg Tablet if you have ever had hypotension.

Verquvo 2.5 mg Tablet may not be recommended for patients with severe anaemia (does not have enough healthy red blood cells); inform your doctor before using Verquvo 2.5 mg Tablet if you have ever had anaemia.

Entresto and Verquvo 2.5 mg Tablet are both medications used to manage heart failure, but they work in different ways and have distinct uses. Entresto contains sacubitril/valsartan, while Verquvo 2.5 mg Tablet contains Vericiguat. Both medications have shown effectiveness in managing heart failure and reducing hospitalizations. The choice between them may depend on individual patient factors, such as medical history, current symptoms, and overall health. Ultimately, the decision between Entresto and Verquvo 2.5 mg Tablet should be made in consultation with your doctor, who can consider your medical history and needs.

Verquvo 2.5 mg Tablet should be taken once daily with food. The specific time of day is not as important as taking it consistently at the same time each day to maintain an even level in your blood. If you have any concerns or specific instructions from your healthcare provider, it is best to follow their guidance.

Verquvo 2.5 mg Tablet is primarily used to reduce the risk of cardiovascular death and heart failure hospitalization in patients with symptomatic chronic heart failure with reduced ejection fraction (HFrEF). While Verquvo 2.5 mg Tablet helps improve heart function by enhancing the production of cyclic guanosine monophosphate (cGMP), which relaxes blood vessels and reduces the workload on the heart, it does not directly improve ejection fraction.

Your doctor will determine the dosing of Verquvo 2.5 mg Tablet and prescribe the appropriate dose based on various factors, such as your medical condition, response to treatment, and ability to tolerate the medication.

No, Verquvo 2.5 mg Tablet should not be taken during pregnancy. It may cause fetal harm when administered to a pregnant woman. It is important to exclude pregnancy before starting treatment with Verquvo 2.5 mg Tablet and to use effective contraception during treatment and for at least one month after stopping the medication.

Vericiguat can lower blood pressure, and hypotension (low blood pressure) is a common side effect of this medication. If you experience symptoms such as dizziness or lightheadedness, taking precautions to avoid falls or injuries is essential. To cope with these symptoms, sit or lie down immediately if you feel dizzy, stay hydrated by drinking plenty of water, avoid standing for long periods, rise slowly from sitting or lying down positions, and avoid heavy lifting or bending. However, consult your healthcare provider for guidance if symptoms persist or worsen.

Heart failure can present a variety of symptoms, some of which may be subtle and easily overlooked. Here are some common symptoms to watch out for: shortness of breath with activity or when lying down, fatigue and weakness, swelling in the legs, ankles and feet, rapid or irregular heartbeat, wheezing, very fast weight gain from fluid buildup, nausea and lack of appetite, difficulty concentrating or decreased alertness, chest pain if a heart attack causes heart failure. If you or someone you know is experiencing these symptoms, it is essential to seek medical attention for proper evaluation and management.

Making positive lifestyle changes can significantly impact heart failure management and overall health. Some key lifestyle modifications that can make a difference are maintaining a healthy diet, regular exercise, weight management, managing stress, quitting smoking, limiting alcohol, and following medical advice.

A heart-healthy diet is designed to support cardiovascular health and reduce the risk of heart disease. Some key components of a heart-healthy diet are Fruits and Vegetables, limited added sugars, moderate alcohol intake, whole grains, lean proteins, and Hydration. Following these guidelines can help protect your heart and improve your overall well-being.

Country of origin

India

Manufacturer/Marketer address

Bayer Ag, Mã¼Llerstr. 178, 13353 Berlin
Other Info - VER0492

Customers Also Bought

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Author Details

Bayyarapu Mahesh KumarDoctor badge

Written By

Bayyarapu Mahesh Kumar

M Pharmacy

Santoshini Reddy GDoctor badge

Reviewed By

Santoshini Reddy G

M Pharmacy

Last Updated

Jul 18, 2025 | 7:06 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

Reference

  1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214377s000lbl.pdf
  2. https://www.verquvo-us.com/
  3. https://medlineplus.gov/druginfo/meds/a621014.html#:~:text=Vericiguat%20is%20in%20a%20class,guanylate%20cyclase%20(sGC)%20stimulators.
  4. https://go.drugbank.com/drugs/DB15456

Buy best Cardiology products by

whatsapp Floating Button

Recommended for a 30-day course: 3 Strips

Buy Now
Add 3 Strips